nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Algeria's response to COVID-19: an ongoing journey
|
Klouche-Djedid, Selma Nihel |
|
|
9 |
5 |
p. 449 |
artikel |
2 |
Bronchial thermoplasty: 10 years and counting
|
Langton, David |
|
|
9 |
5 |
p. 436-437 |
artikel |
3 |
Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses
|
Song, Woo-Jung |
|
|
9 |
5 |
p. 533-544 |
artikel |
4 |
Correction to Lancet Respir Med 2021; published online March 26. https://doi.org/10.1016/S2213-2600(21)00169-7
|
|
|
|
9 |
5 |
p. e49 |
artikel |
5 |
Could a good night's sleep improve COVID-19 vaccine efficacy?
|
Benedict, Christian |
|
|
9 |
5 |
p. 447-448 |
artikel |
6 |
COVID-19 severity and obesity: are MAIT cells a factor?
|
McCarthy, Cormac |
|
|
9 |
5 |
p. 445-447 |
artikel |
7 |
COVID-19 vaccination in athletes: ready, set, go…
|
Hull, James H |
|
|
9 |
5 |
p. 455-456 |
artikel |
8 |
Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
|
Bharat, Ankit |
|
|
9 |
5 |
p. 487-497 |
artikel |
9 |
European guideline on managing adults in hospital with COVID-19
|
Venkatesan, Priya |
|
|
9 |
5 |
p. e50 |
artikel |
10 |
IL-6 blockade for COVID-19: a global scientific call to arms
|
Murthy, Srinivas |
|
|
9 |
5 |
p. 438-440 |
artikel |
11 |
Into the abyss
|
Bigham, Blair |
|
|
9 |
5 |
p. 452-453 |
artikel |
12 |
Major differences in ICU admissions during the first and second COVID-19 wave in Germany
|
Karagiannidis, Christian |
|
|
9 |
5 |
p. e47-e48 |
artikel |
13 |
Neutrophilic asthma: misconception or misnomer?
|
Nair, Parameswaran |
|
|
9 |
5 |
p. 441-443 |
artikel |
14 |
Pandemic fans the flames of smoking and health inequity
|
The Lancet Respiratory Medicine, |
|
|
9 |
5 |
p. 435 |
artikel |
15 |
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
|
Feld, Jordan J |
|
|
9 |
5 |
p. 498-510 |
artikel |
16 |
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
|
Theelen, Willemijn S M E |
|
|
9 |
5 |
p. 467-475 |
artikel |
17 |
Pirfenidone in patients with non-IPF progressive fibrotic interstitial lung diseases: expert guidance is urgently needed
|
Wells, Athol U |
|
|
9 |
5 |
p. 437-438 |
artikel |
18 |
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|
Behr, Jürgen |
|
|
9 |
5 |
p. 476-486 |
artikel |
19 |
Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials
|
Chaudhuri, Rekha |
|
|
9 |
5 |
p. 457-466 |
artikel |
20 |
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
|
Lescure, François-Xavier |
|
|
9 |
5 |
p. 522-532 |
artikel |
21 |
Separation—a letter to my child
|
Goh, Orlanda |
|
|
9 |
5 |
p. 450-451 |
artikel |
22 |
The Troublemaker
|
Paul, Trisha K |
|
|
9 |
5 |
p. 451-452 |
artikel |
23 |
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
|
Soin, Arvinder S |
|
|
9 |
5 |
p. 511-521 |
artikel |
24 |
Treatment of mild-to-moderate asthma in childhood and adolescence in 2021
|
Abrams, Elissa M |
|
|
9 |
5 |
p. 443-445 |
artikel |
25 |
Young person with long COVID after mild disease
|
Kirby, Tony |
|
|
9 |
5 |
p. 453-455 |
artikel |